相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sensing of energy and nutrients by AMP-activated protein kinase
D. Grahame Hardie
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice
A. Maida et al.
DIABETOLOGIA (2011)
Influence of Diabetes Mellitus and Hyperglycemia on Prognosis in Patients ≥70 Years Old With Heart Failure and Effects of Nebivolol (Data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure [SENIORS])
Rudolf A. de Boer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species-Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
Hisko Oeseburg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1-Smad3 signalling pathway
Han Xiao et al.
CARDIOVASCULAR RESEARCH (2010)
Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case-Control Study From the UK General Practice Research Database
Michael R. MacDonald et al.
DIABETES CARE (2010)
Diabetes, Glycemic Control, and New-Onset Heart Failure in Patients With Stable Coronary Artery Disease Data from the Heart and Soul Study
Joost P. van Melle et al.
DIABETES CARE (2010)
Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo
Irma Kuipers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents
Ippei Shimizu et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
AMP-activated protein kinase confers protection against TNF-α-induced cardiac cell death
Girish Kewalramani et al.
CARDIOVASCULAR RESEARCH (2009)
Metformin Prevents Progression of Heart Failure in Dogs Role of AMP-Activated Protein Kinase
Hideyuki Sasaki et al.
CIRCULATION (2009)
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Susheel Gundewar et al.
CIRCULATION RESEARCH (2009)
AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
Aaron K. F. Wong et al.
CLINICAL SCIENCE (2009)
Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes
J. Cuthbertson et al.
DIABETIC MEDICINE (2009)
Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration
Lasse Solskov et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure
Michael R. MacDonald et al.
EUROPEAN HEART JOURNAL (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Kenneth Dickstein et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling
John W. Calvert et al.
DIABETES (2008)
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review
Dean T. Eurich et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization
B. Daan Westenbrink et al.
EUROPEAN HEART JOURNAL (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Identification of potential caloric restriction mimetics by microarray profiling
JM Dhahbi et al.
PHYSIOLOGICAL GENOMICS (2005)
The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects
AP James et al.
DIABETES OBESITY & METABOLISM (2005)
Effects of KATP channel modulation on myocardial glycogen content, lactate, and amino acids in nonischemic and ischemic rat hearts
SB Kristiansen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure - An observational study
FA Masoudi et al.
CIRCULATION (2005)
Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy
AYM Chan et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2005)
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27
RA de Boer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo -: Role of mitochondrial reactive nitrogen species (Publication with Expression of Concern. See vol. 294, pg. 10024, 2019) (Withdrawn Publication. See vol. 294, pg. 13525, 2019)
MH Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status
DG Hardie
ENDOCRINOLOGY (2003)
Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart
S Kovacic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
AMP-activated protein kinase and muscle glucose uptake
N Musi et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2003)
Increased expression of cardiac angiotensin II type 1 (AT1) receptors decreases myocardial microvessel density after experimental myocardial infarction
RA de Boer et al.
CARDIOVASCULAR RESEARCH (2003)
Metformin: An update
D Kirpichnikov et al.
ANNALS OF INTERNAL MEDICINE (2002)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure
RA De Boer et al.
JOURNAL OF CARDIAC FAILURE (2000)
分享论文
